Poster Sessions

BOARD A1
Defining the elements of early palliative care (PC) that are associated with patient-reported outcomes (PROs) and the delivery of end-of-life (EOL) care. (Abstract 154)
First Author: Michael Hoerger, PhD, MS


BOARD A2
Economic impact of palliative care among elderly cancer patients. (Abstract 91)
First Author: Wendi Lebrett


BOARD A3
Effects of examination room computer on cancer patients perception of physician's compassion, communication skills, and professionalism: A randomized clinical trial. (Abstract 26)
First Author: Ali Haider, MD


BOARD A4
Integration of palliative care into oncology: A curriculum development project. (Abstract 202)
First Author: Charles Von Gunten, MD, PhD


BOARD B1
Pharmacokinetics/pharmacodynamics (PK/PD), safety, and tolerability of fosaprepitant for the prevention of chemotherapy-induced nausea and vomiting (CINV) in pediatric subjects. (Abstract 93)
First Author: Jaume Mora


BOARD B2
Using electronic patient reported outcomes to identify gaps in quality of care in radiation oncology. (Abstract 94)
First Author: Celine Marquez, MD


BOARD B3
Impact of palliative care rotation on gynecologic oncology fellows' knowledge, rates of explicit teaching, and perceived competence in palliative care. (Abstract 95)
First Author: Carolyn Lefkowits, MD, MPH


BOARD B4
A grounded theory analysis of oncology nurses' perceptions of early palliative care in the context of ambulatory care. (Abstract 96)
First Author: Shan Mohammed


BOARD B5
Impact of a clinical pathway tool on appropriate palliative radiation therapy for bone metastases. (Abstract 97)
First Author: Lisa Rotenstein, MD, MBA


BOARD B6
Nurses’ roles and responsibilities in the provision of early palliative care: A grounded theory study (Abstract 98)
First Author: Shan Mohammed


BOARD B7
Development of a telemedicine palliative care program in a cancer center. (Abstract 99)
First Author: Youngho Kim, MD


BOARD B8
Need for nutritional support in advanced cancer patients with cachexia: A survey in palliative care settings. (Abstract 100)
First Author: Koji Amano, MD


BOARD B9
Impact of socioeconomic status on pretreatment cachexia and survival in non-small cell lung cancer. (Abstract 101)
First Author: Steven Lau, MD, PhD


BOARD B10
Disparity in use of supportive resources in elderly patients on chemotherapy for gastrointestinal malignancies: A single institution analysis. (Abstract 102)
First Author: Prashant J. Joshi, MD


BOARD C1
The utilization of inpatient palliative care services (PCS) in patients with metastatic cancer receiving critical care therapies (CCTs). (Abstract 103)
First Author: Kah Poh Loh, MBBCh


BOARD C2
African American perceptions of early palliative care in oncology. (Abstract 104)
First Author: William Pirl, MD, MPH


BOARD C3
Engaging oncologists toward integrating a shared mental model for palliative oncology within a large academic oncology practice. (Abstract 105)
First Author: Anne Walling, MD, PhD


BOARD C4
The expanding role of patients in integrated cancer network governance. (Abstract 106)
First Author: Dominique Tremblay, PhD


BOARD C5
Palliative care in a community-based oncology private practice. (Abstract 107)
First Author: Loren Friedman, MD


BOARD C6
Comparison of hydration events in patients (pts) receiving highly (HEC) or moderately (MEC) emetogenic chemotherapy treated with granisetron extended-release subcutaneous (GERSC) or palonosetron (PALO). (Abstract 108)
First Author: Jeffrey Vacirca, MD, FACP


BOARD C7
Palliative care in the ambulatory setting: Bon Secours St. Francis Hospital (BSSFH). (Abstract 109)
First Author: Jennifer Ashley, MSN, FNP-BC


BOARD C8
Palliative care utilization in oncology patients with 30-day hospital readmission. (Abstract 110)
First Author: Chintan Pandya, MBBS, MPH, PhD


BOARD C9
Palliative care from cancer diagnosis for all: Memorial Sloan Kettering’s “One-Two-Three” program. (Abstract 111)
First Author: Andrew Epstein, MD


BOARD C10
Utilization of support services, emergency department, and hospital in advanced cancer patients with severe disease in a community cancer institute. (Abstract 112)
First Author: Caitlyn McNaughton, PA-C, MHSc, MA


BOARD C11
Preliminary results of a randomized controlled trial of early integration of specialist palliative care within a tertiary cancer center in the Czech Republic. (Abstract 113)
First Author: Ondrej Slama, MD, PhD


BOARD C12
Exploring the association between KRAS mutations and depression in non-small cell lung cancer (NSCLC) patients. (Abstract 114)
First Author: Jenny Li, MD, BS


BOARD D1
Relevance of rapid geriatric assessment for elderly patients with newly diagnosed malignancy. (Abstract 115)
First Author: Hina Mehta


BOARD D2
Towards personalized surveillance for head and neck cancer patients. (Abstract 116)
First Author: Sven Alders, BSc


BOARD D3
A retrospective review of patients with hematological malignancy referred to an inpatient palliative care service in a tertiary hospital. (Abstract 117)
First Author: Yee Meng, MBBS, MRCP (UK)


BOARD D4
Education of residents in palliative and hospice care. (Abstract 118)
First Author: Ela Eris, MD


BOARD D5
Impact of pharmacy interventions on pain management in an oncology palliative medicine (PM) outpatient clinic. (Abstract 119)
First Author: Jai Patel, PharmD


BOARD D6
Evaluation of daily breakthrough chemotherapy-induced nausea and vomiting (CINV) rates in a phase III study of NEPA versus an aprepitant (APR)/granisetron (GRAN) regimen. (Abstract 120)
First Author: Eric Roeland, MD


BOARD D7
Barriers between providers and families regarding palliative care integration in a multidisciplinary pediatric oncology practice. (Abstract 121)
First Author: Lauren Draper, MD


BOARD D8
Phase III safety evaluation of intravenous NEPA, a novel fixed antiemetic combination of fosnetupitant and palonosetron, over multiple cycles. (Abstract 122)
First Author: Lee Schwartzberg, MD, FACP


BOARD D9
The utilization and impact of oncology supportive care clinics on patients with metastatic lung cancer. (Abstract 123)
First Author: Yan Kim, MD PhD


BOARD D10
The influence of a cachexia clinic on palliative care integration in oncology. (Abstract 124)
First Author: Diane Portman, MD, FAAHPM


BOARD D11
Randomized controlled trial (RCT) of a dyadic yoga program for lung cancer patients undergoing radiotherapy and their family caregivers. (Abstract 125)
First Author: Kathrin Milbury, PhD


BOARD D12
Integration and expansion of palliative care work force. (Abstract 126)
First Author: Lynn Bowlby


BOARD E1
Interdisciplinary palliative care services for cancer patients: Assessing quality of care and outcomes measures of successful intervention. (Abstract 127)
First Author: Yun Li, MD, PhD


BOARD E2
Palliative Care Early and Systematic (PaCES): A survey of colorectal cancer clinicians of barriers and facilitators to early palliative care integration. (Abstract 128)
First Author: Sharon Watanabe, MD


BOARD E3
Impact of palliative care (PC) consultation on quality of end-of-life (EOL) care in advanced cancer patients receiving care at a tertiary cancer center (TCC). (Abstract 129)
First Author: Sharon Watanabe, MD


BOARD E4
Toxicity of sequential immune therapy and radiation for cervical and thoracic spine metastases. (Abstract 130)
First Author: W. Tristram Arscott


BOARD E5
The outcome of outpatient palliative care service at Yonsei Cancer Center, a tertiary cancer center in Korea. (Abstract 131)
First Author: Si Won Lee, MD


BOARD E6
Objective smartphone measurements of physical activity and fitness in patients with cancer. (Abstract 132)
First Author: Joeri Douma, MD


BOARD E7
Health-related quality of life of postmenopausal women with hormone receptor–positive, HER2− advanced breast cancer treated with ribociclib + letrozole: Results from MONALEESA-2. (Abstract 133)
First Author: Sunil Verma, MD


BOARD E8
Comprehensive distress screening and referral at a tertiary cancer center. (Abstract 134)
First Author: Elizabeth Loggers, MD, PhD


BOARD E9
Characteristics of urgent palliative cancer care consultations encountered by radiation oncologists. (Abstract 135)
First Author: Muhammad Fareed


BOARD E10
Early integration of supportive oncology consultation for hospitalized cancer patients. (Abstract 136)
First Author: Kellie Woodfield


BOARD E11
Palliative care in hematologic oncology: A needs assessment. (Abstract 137)
First Author: Gene DeCastro, MD, MA


BOARD E12
Triple threat of mortality among advance cancer patients presenting to an emergency department. (Abstract 138)
First Author: Ahmed Elsayem, MD


BOARD F1
Access to early palliative care in a cancer center in Mexico. (Abstract 139)
First Author: Mirza Alcalde Castro, MD


BOARD F2
Overcoming recruitment challenges in a randomized clinical trial of early palliative care. (Abstract 140)
First Author: Susanne Zwahlen, MD


BOARD F3
A three step process to create a palliative medicine co-management model of care on an inpatient hematology unit. (Abstract 141)
First Author: Gene DeCastro, MD, MA


BOARD F4
Successful integration of palliative care services into the multidisciplinary multiple myeloma clinics: An observational study based on a single institution experience. (Abstract 142)
First Author: Neil Nagovski, MD


BOARD F5
Role of palliative radiotherapy (PRT) in patients with malignant airway obstruction (MAO) in the intensive care unit (ICU). (Abstract 143)
First Author: Alireza Fotouhi Ghiam


BOARD F6
Implementation of a multidisciplinary palliative and supportive care education lecture series. (Abstract 144)
First Author: Shawna Chan


BOARD F7
Using a framework for resource stratification to adapt palliative care guidelines to Sub-Saharan Africa. (Abstract 145)
First Author: Maria Dans


BOARD F8
Areas for quality improvement in pediatric supportive oncology services. (Abstract 146)
First Author: Jennifer Reichek, MD


BOARD F9
Standardization of inpatient CPR status discussions and documentation within the Division of Hematology and Oncology at UPMC Shadyside Hospital. (Abstract 147)
First Author: Christine Garcia, MD, MPH


BOARD F10
Perceptions of palliative care: Cancer and non-cancer. (Abstract 148)
First Author: Ingrid Harle, MD, FRCSC, CCFP-PC


BOARD F11
Call to integrate supportive care and patient reported outcomes in early phase clinical trials: An exploration of adolescent and young adult (AYA) participation on phase I trials of novel anticancer agents. (Abstract 149)
First Author: Ishwaria Subbiah, MD, MS


BOARD F12
Raising all boats in supportive oncology: Initial impact of the Coleman Supportive Oncology Collaborative (CSOC). (Abstract 150)
First Author: James Gerhart, PhD


BOARD G1
Practice patterns in radiation therapy for bone metastases in multiple histologies. (Abstract 151)
First Author: Trent Taylor, BS


BOARD G2
Integration of supportive care in immuno-oncology trials: Investigating the incidence and severity of immune-related toxicities among older adults versus mid-age patients on immunotherapy-based phase I clinical trials. (Abstract 152)
First Author: Ishwaria Subbiah, MD, MS


BOARD G3
Implications for the future of palliative care for pancreatic cancer: A retrospective institutional study. (Abstract 153)
First Author: Alina Basnet, MD


BOARD G4
Hospitalization costs for nausea and vomiting: A savings opportunity. (Abstract 155)
First Author: Eric Roeland, MD


BOARD G5
Evaluation of family perceptions of palliative medicine department family meetings: Before, during, and after. (Abstract 156)
First Author: Andrea Cartin


BOARD G6
Living goals: Prepare to die. (Abstract 157)
First Author: Zankhana Mehta


BOARD G7
Novel malignant bowel obstruction (MBO) management program for women with advanced gynecological cancer. (Abstract 158)
First Author: Yeh Chen Lee, MBBS


BOARD G8
Multidisciplinary osteoncologic approach to bone metastases: Analysis of a large, mono-institutional cohort. (Abstract 159)
First Author: Marco Maruzzo, MD


BOARD H1
Outcomes of an innovative six-week standardized residential training course for physicians and nurses to provide primary palliative care in India. (Abstract 160)
First Author: Suresh Reddy, MD


BOARD H2
Development of a serious illness care model implementation framework. (Abstract 161)
First Author: Khue Nguyen


BOARD H3
Propensity score matched analysis of a palliative radiation oncology consult service’s impact on length of stay and total costs during hospitalization. (Abstract 162)
First Author: Sanders Chang, MSc


BOARD H4
Evaluation of an NP-based model of palliative care delivery within an oncology clinic. (Abstract 163)
First Author: Sarah DAmbruoso, MSN


BOARD H5
Treatment, logistical, and cost burden of prior authorization in community practice. (Abstract 164)
First Author: Ajaz Bulbul, MD, MBBS


BOARD H6
Could payer mix affect length of stay or readmissions among an outpatient palliative care cohort? (Abstract 165)
First Author: Ali John Zarrabi


BOARD J1
Demographics and disposition of patients in an academic outpatient palliative care practice. (Abstract 166)
First Author: Ali John Zarrabi


BOARD J2
First referral to an integrated onco-palliative care program: A retrospective analysis of its timing. (Abstract 167)
First Author: Claire Barth


BOARD J3
Models of care for serious illness: What is the evidence? (Abstract 168)
First Author: Robin Whitney, PhD, RN, BS, BA


BOARD J4
Simultaneous Care clinic (SCC): A three-year monoinstituional experience. (Abstract 169)
First Author: Silvia Stragliotto, MD


BOARD J5
Supportive care day hospital: A new tool for palliative care in cancer centers. (Abstract 170)
First Author: Carole Bouleuc


BOARD J6
Implementation of an interdisciplinary care team to create individualized care plans for high risk oncology patients: A model to decrease aggressiveness of care at the end of life and improve cost effectiveness of care. (Abstract 171)
First Author: Girish Kunapareddy, MD


BOARD J7
Early specialist palliative care for all hospitalized advanced cancer patients (ACP)? Effect of “up-front” versus “on demand” palliative care on outcomes. (Abstract 172)
First Author: Monica Malec, MD


BOARD J8
Development of a Prompt Radiation Oncology Mediated Palliative Treatment (PROMPT) program for handling urgent cases at an academic hospital. (Abstract 173)
First Author: Jared Robbins, MD


BOARD J9
Optimizing dosing in navigation interventions across the cancer continuum: A planned secondary data analysis from the Patient Care Connect implementation. (Abstract 174)
First Author: Elizabeth Kvale, MD


BOARD J10
Incidence of palmar-plantar erythrodysesthesia and hypothyroidism in patients with metastatic cancer treated with cabozantinib: A systematic review and meta-analysis of randomized controlled trials. (Abstract 204)
First Author: Kyaw Thein, MD, MBBS


BOARD J11
Illicit substance use and opioid misuse in adolescent and young adult (AYA) cancer patients. (Abstract 205)
First Author: Ritika Oberoi-Jassal, MD


BOARD J13
Risk of hematological toxicities and febrile neutropenia in patients with hormone receptor-positive HER2-negative metastatic breast cancer treated with CDK 4/6 inhibitors: A systematic review and meta-analysis of randomized controlled trials. (Abstract 207)
First Author: Myo Zaw, MBBS


BOARD J14
Risk of gastrointestinal and hepatic toxicities in patients with metastatic solid tumors treated with cabozantinib: A systematic review and meta-analysis of randomized controlled trials. (Abstract 208)
First Author: Myo Zaw, MBBS


BOARD K1
A systematic review and meta-analysis of randomized controlled trials to evaluate the risk of gastrointestinal and hepatic toxicities in patients with hormone receptor-positive HER2-negative metastatic breast cancer treated with CDK 4/6 inhibitors. (Abstract 209)
First Author: Myo Zaw, MBBS


BOARD K2
Opioid epidemic or pain crisis? Exploring prescription opioid medication utilization for patients with cancer in rural Southwest Virginia. (Abstract 210)
First Author: Virginia LeBaron, PhD, APRN-BC


BOARD K3
Validity and reliability of Korean version of simplified nutritional appetite questionnaire in patients with advanced cancer: A multicenter, longitudinal study. (Abstract 211)
First Author: Su-Jin Koh, MD, PhD


BOARD K4
Outcomes of a specialized interdisciplinary approach for cancer patients with aberrant opioid-related behavior: A preliminary report. (Abstract 212)
First Author: Tonya Edwards, RN, MS, BSN, CCRP


BOARD K5
A systematic review and meta-analysis of randomized controlled trials to evaluate the risk of fatigue and pain among patients treated with ibrutinib. (Abstract 213)
First Author: Myo Zaw, MBBS


BOARD K6
A systematic review and meta-analysis of randomized controlled trials to evaluate the risk of fatigue and pain among patients with metastatic solid tumors treated with cabozantinib. (Abstract 214)
First Author: Myat Han


BOARD K7
Risk of health-related quality of life events from pain and fatigue among patients with hormone receptor-positive HER-2 negative metastatic breast cancer treated with CDK 4/6 inhibitor. (Abstract 215)
First Author: Myat Han


BOARD K8
Risk factors and prophylaxis of irinotecan induced cholinergic syndrome in sight of supportive care. (Abstract 216)
First Author: Hiroyuki Fujii, MD


BOARD K9
A comparison of Numeric Pain Rating Scale (NPRS) and the Visual Analog Scale (VAS) in patients with chronic cancer-associated pain. (Abstract 217)
First Author: Shagufta Firdous


BOARD K10
Modeling of quality of life in older adults with advanced cancer: Data from a URCC NCORP multisite trial. (Abstract 218)
First Author: Marie Flannery, PhD, RN, AOCN


BOARD K11
Nasal vestibulitis as an under-recognized and undertreated side effect of cancer treatment. (Abstract 219)
First Author: Elizabeth Cathcart-Rake, MD


BOARD K12
Atypical femoral fracture in patients with malignant bone metastasis receiving denosumab therapy: Retrospective study. (Abstract 220)
First Author: Yukinori Ozaki


BOARD K13
Level of burden of supportive care-relevant pharmacogenetic markers in general population. (Abstract 221)
First Author: Howard McLeod, PharmD


BOARD K14
Trismus and reduced quality of life in patients with oral squamous cell carcinoma who received postoperative radiotherapy alone or combined with chemotherapy. (Abstract 222)
First Author: Ourania Nicolatou-Galitis, DDS


BOARD L1
Analysis of retreatment after radiotherapy for bone metastasis at a safety net hospital. (Abstract 223)
First Author: Richard Jennelle, MD


BOARD L2
Methadone as the initial long-acting opioid in children with advanced cancer. (Abstract 224)
First Author: Kevin Madden, MD


BOARD L3
Off-label drug use in home palliative care: A non-evidence-based established practice. (Abstract 225)
First Author: Laura Velutti, MD


BOARD L4
Opioid switch and change of route of administration in palliative care cancer patients treated by morphine: Update of French guidelines. (Abstract 226)
First Author: Philippe Poulain, MD


BOARD L5
Phase III study of palonosetron (PALO) given as 30-min IV infusion (IV inf) versus 30-sec IV bolus (IV bol) for prevention of chemotherapy-induced nausea and vomiting (CINV) associated with highly emetogenic chemotherapy (HEC). (Abstract 227)
First Author: Meinolf Karthaus, MD


BOARD L6
Frequency and factors predicting the risk for aberrant opioid use in patients receiving outpatient palliative care at a comprehensive cancer center. (Abstract 228)
First Author: Sriram Yennu, MD


BOARD L7
Cranial electrotherapy stimulation for the management of depression, anxiety, sleep disturbance, and pain in patients with advanced cancer: A preliminary study. (Abstract 229)
First Author: Sriram Yennu, MD


BOARD L8
Randomized trial of a smartphone mobile app for adherence to oral chemotherapy. (Abstract 230)
First Author: Jamie Jacobs, PhD


BOARD L9
Efficacy and side effect profile of olanzapine versus haloperidol for symptoms of delirium in hospitalized patients with advanced cancer: A multicenter, investigator-blinded, randomized, controlled trial (RCT). (Abstract 231)
First Author: Maurice van der Vorst, MD


BOARD L10
Development of a digital tool to assess the risk of thromboembolic disease and prescription of prophylactic anti-thrombotic therapy in oncologic patients. (Abstract 232)
First Author: Lizbett Garcia Montes, MD


BOARD L11
Effect of palliative surgery, chemotherapy, and radiation in stage IV pancreatic cancer. (Abstract 233)
First Author: Brooke Vuong, MD, MHA


BOARD L12
Novel approach for cancer-related fatigue: A double-blind randomized clinical trial. (Abstract 234)
First Author: Claudia Sette, MD


BOARD L13
Health providers’ perspectives on medical marijuana use. (Abstract 235)
First Author: Diana Martins-Welch, MD


BOARD L14
Long term efficacy and safety of duloxetine in the management of painful chemotherapy induced peripheral neuropathy. (Abstract 236)
First Author: Sang Mi Ro, M


BOARD M1
Health related quality of life in patients with advanced colorectal cancer treated with dose reduced capecitabine. (Abstract 237)
First Author: Daniel Breadner, MD


BOARD M2
Cancer-related fatigue in cancer survivors (CS) with no active treatment. (Abstract 238)
First Author: Maria Soriano


BOARD M3
Common AEs associated with CDK4/6 inhibitors in patients with hormone receptor–positive advanced breast cancer. (Abstract 239)
First Author: Denise Yardley, MD


BOARD M4
Frequency of concomitant use of opioids and psychoactive medications among cancer patients referred to outpatient palliative care at a comprehensive cancer center. (Abstract 240)
First Author: Ahsan Azhar, MBBS, MD


BOARD M5
Utilization of gabapentin for cough in cancer: A case series. (Abstract 241)
First Author: Josephine Feliciano, MD


BOARD M6
Stereotactic body radiation therapy for palliative treatment of bone metastases: Practice patterns and survival outcomes. (Abstract 242)
First Author: Catherine Kinchen, BS


BOARD M7
Patient engagement with a smartphone mobile app for adherence to oral chemotherapy. (Abstract 243)
First Author: Molly Ream, BA


BOARD M8
Scrambler therapy for the treatment of chronic central pain due to cavernous hemangioma in the midbrain: A model for treating central cancer pain. (Abstract 244)
First Author: Thomas Smith, MD, FASCO, FAAHPM


BOARD M9
Cannabis use in palliative care: The prevalence and clinical characteristics. (Abstract 245)
First Author: Young Chang, MD


BOARD M10
Palliation of urinary obstruction from advanced prostate cancer with SBRT. (Abstract 246)
First Author: Lauren Boreta, BS, MD


BOARD M12
Comparing physician and nurse ECOG performance status ratings as predictors of clinical outcomes in cancer patients. (Abstract 248)
First Author: Elad Neeman, MD


BOARD N1
BMI and health-related quality of life (HR-QoL) in patients with metastatic colorectal cancer (mCRC). (Abstract 249)
First Author: Vincenzo Formica, MD


BOARD N2
Assessment of the impact of the Hospital Anxiety and Depression Scale on the initiation of treatment in newly diagnosed cancer patients in a safety-net hospital. (Abstract 250)
First Author: Daulath Singh, MD


BOARD N3
Biomarkers to evaluate distress in cancer patients. (Abstract 251)
First Author: Elise Labbe-Coldsmith,


BOARD N4
Factors affecting adherence to standard cisplatin (CDDP)-based chemotherapy regimen for locally advanced squamous cell head and neck (H&N) cancer in an inner city safety net hospital. (Abstract 252)
First Author: Sunny R. K. Singh, MBBS


BOARD N5
Standardizing opioid prescribing practices for cancer-related pain via a novel interactive documentation template at a public hospital. (Abstract 253)
First Author: Maliha Nusrat, MBBS


BOARD N6
Ultrasound application in point of care by palliative medicine physicians: Initial experience of oncology palliative medicine consultation in two rural area hospitals in Costa Rica. (Abstract 254)
First Author: Karol Villalobos